Update README.md

README.md

@@ -1,3 +1,32 @@
----
-license: cc-by-4.0
----
+---
+license: cc-by-nc-4.0
+pretty_name: Global Drug Development & Classification
+tags:
+- pharmacology
+- drug-development
+- nme
+- first-in-class
+task_categories:
+- tabular-classification
+size_categories:
+- 1K<n<10K
+---
+
+💊 Dataset Summary
+
+The Global Drug Development & Classification Database contains 1,000 pharmaceutical assets sampled across all development stages, with deliberate enrichment of early-phase compounds (Preclinical, Phase I, Phase II) to support discovery-stage AI research. It tracks regulatory milestones including New Molecular Entity (NME), First-in-Class, and Qualified Infectious Disease Product (QIDP) designations.
+
+🚀 Key Features
+
+•
+Phase-Enriched Sampling: Early-stage compounds are over-represented to support discovery and lead optimization workflows.
+
+•
+Regulatory Milestones: Boolean flags for is_nme, is_first_in_class, and is_qidp.
+
+•
+Global Development Tracking: global_highest_dev_status captures a drug's current progression from discovery to approval.
+
+💻 Quick Start & MCP Integration
+
+Connect your AI agents to global drug intelligence using our Drug Discovery MCP Tool on GitHub.